A clinical trial known as Evidence for Contraceptive Options and HIV Outcomes (ECHO)—originally designed to answer important questions about possible connections between risk of HIV infection and the use of non-barrier hormonal contraceptives—now hangs in the balance because of a funding shortfall. Lillian Mworeko and others issue a clarion call for funding in light of the needs of women in the context of HIV. Read full article here